Home › Lung Diseases › Utah
Lung Diseases clinical trials in Utah
7 studies for Lung Diseases are looking for participants at sites in Utah.
Cities in Utah
A Study of COVID-19 Vaccine(s) in Children and Adults
- J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
- J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City
RecruitingPhase 3Healthy volunteers welcome
Ages 5 and older · All sexes · Updated Sep 28, 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Alpine Research Organization, Clinton
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06572384Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Salt Lake City
- Research Site, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05624450A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
RecruitingPhase 4Healthy volunteers welcome
Ages 18 to 64 · All sexes · Updated Aug 7, 2026 · NCT07730450Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Recruiting
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT05297734A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Intermountain Health, Salt Lake City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.